Allograft rejection in pediatric recipients of living related liver transplants. 1996

E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
Department of Pediatrics, University of Chicago, Pritzker School of Medicine, Wyler Children's Hospital, IL, USA.

The purpose of this study was to compare the incidence and severity of rejection episodes in a group of children receiving living related orthotopic liver transplants (LRLT) versus children receiving cadaveric liver transplants (CLT). Thirty-eight patients received primary LRLT and 54 patients received CLT during a 3-year period ending June 1993. Baseline immunosuppression consisted of cyclosporin, azathioprine, and corticosteroids. Rejection episodes were confirmed by liver histology and were treated initially with pulse intravenous methylprednisolone, 10 mg/kg/d for 3 days. Steroid-resistant rejection was treated with OKT3 or FK506. The median patient ages were 1.3 years for the CLT and .8 years for the LRLT recipients. Acute cellular rejection developed in 78% of the CLT grafts and 74% of the LRLT grafts (P = ns). However, steroid-resistant rejection was significantly less frequent in the LRLT recipients, 13% versus 43% in the CLT recipients (P < .01). Ductopenic rejection was diagnosed in 20% of CLT and 8% of LRLT grafts (P < .10), and graft loss caused by rejection was 9% in the CLT and 3% in the LRLT group (P = ns). In conclusion, the overall incidence of rejection is the same in LRLT and CLT recipients, but LRLT recipients are less likely than CLT recipients to develop steroid-resistant rejection or ductopenic rejection.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
August 2002, Pediatric transplantation,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
January 2012, JAMA,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
November 2006, Transplantation proceedings,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
November 1998, Transplantation proceedings,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
November 1998, Transplantation proceedings,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
June 1998, Transplantation proceedings,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
February 1995, Critical care nursing quarterly,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
December 2018, Gastroenterology,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
October 1996, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
E M Alonso, and J B Piper, and G Echols, and J R Thistlethwaite, and P F Whitington
January 2018, International journal of organ transplantation medicine,
Copied contents to your clipboard!